2018 Investigator’s Award in Cell and Gene Therapy for Cancer – LOI

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit:

Memorial Deadline:

External Deadline: Tuesday 13th, March 2018


Description

Alliance for Cancer Gene Therapy is pleased to announce its 2018 Investigator’s Award in Cell and Gene Therapy for Cancer Request for Applications.

The deadline for submission of abstracts (LOIs) is March 13 at 11 AM EST.  Please see the attached RFA for specifics.  Please submit all grant requirements via proposalCentral:  https://proposalcentral.altum.com/Login.asp.

To interested researchers, please note:

  1. Research Grant and Contract Services is not required to sign off at the LOI stage of this funding opportunity. Please notify your Associate Dean (Research) and Department Head of your intention to submit an LOI to this competition.
  2. If your LOI is selected to go forward to the full application stage, we request that you contact the applicable RGCS individual indicated below at least 10 working days prior to the application deadline, as terms and conditions of the opportunity may require the inclusion of overhead costs (as per the Indirect Cost of Externally Funded Research Policy).
  3. Institutional Review by RGCS will be required at the full application stage. The internal deadline will be noon, May 10, 2018.
  4. When submitting an application for Institutional Review, be sure to include the appropriate Approval Form from your Department/Faculty with the application.

Further details on processes for institutional review and approval are available at http://www.mun.ca/research/funding/grants/institutional-review.php.

Downloads

RFA 2018 Investigator Award


Funding Sources

ALLIANCE FOR CANCER GENE THERAPY



This opportunity was posted by: RGCS

Last modified: January 25, 2018